S&P 500 7,457.69 -1.01% NASDAQ 25,520.24 -1.40% DOW 52,146.42 -0.77% R2K 2,962.22 -0.42% VIX 18.77 +12.19% US 10Y 4.54 -0.61% DXY 100.75 +0.02% GOLD 4,012.70 +0.68% CRUDE 82.49 +4.48% BITCOIN 63,947.73 +0.08%
Next Bullish Trade
Sign in
ARTL

Artelo Biosciences, Inc. ARTL

$1.15 +0.01 (+0.88%)
Neutral · -0.27σ
Mkt cap $0.0B
P/E
Day $1.11 – $1.15
52wk $0.96 – $19.91
Avg vol
Beta
Div yld
Next earnings

Quick read

Plain English

Artelo Biosciences, Inc. is a healthcare company listed in the US.

ARTL last traded at $1.15, up 0.9% on the day; that's in the lower part of its 52-week range ($0.96–$19.91). Right now it's trading close to its recent average, with no strong stretch in either direction.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →
21 EMA +1 ATR +2 ATR −2 ATR
O H L C

Under the hood

On the latest daily bar, momentum sits mid-range (RSI 41), the trend is quiet (ADX 21), and trading is light at 0.3× normal volume.

Latest-bar indicator readings behind the grade — display-only, they don't move the letter.

Momentum · RSI
41
0–100 · <30 oversold
Trend strength · ADX
21
>25 = strong trend
Volume vs avg
0.33×
1× = average
Stretch from avg
-0.1 ATR
− below · + above
Zone touches
0
tests of this zone
Suggested hold
3–30
bars (≈ days)
Fundamentals at a glance

Company fundamentals for context — display-only, they don't move the grade.

Debt / equity
0.11
lower = less leveraged

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Verdict
Unknown
Accounting quality Weak
  • ✓ More cash than debt
  • ⚠ Current ratio 0.17 (fragile)
  • ⚠ Intangibles 73% of assets (fragile asset base)
  • ⚠ Negative retained earnings

Key statistics

All statistics →

ARTL is a $4 million company, the stock is trading near the bottom of its 52-week range.

Mkt cap $0.0B
P/E ttm
Fwd P/E
Beta
Day range $1.11 – $1.15
52w range $0.96 – $19.91
Avg vol
RSI(2) 72.6
ROE
Net mgn
FCF mgn
Debt/Eq 0.11
Div yld
Sector Healthcare
Industry Biotechnology
Next earn
52-week range · today's price
$0.96$19.91

More on ARTL